Literature DB >> 18580619

Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.

Mark Nelson1, Alex Azwa, Ahmed Sokwala, Reena Shah Harania, Justin Stebbing.   

Abstract

We report a case of the nucleoside reverse transcriptase inhibitors, stavudine and lamivudine inducing Fanconi syndrome in a patient. The presence of simultaneous lactic acidosis suggests mitochondrial toxicity within the proximal renal tubular cells as the likely pathogenesis. We recommend that both the above nucleosides be added to the list of antiretroviral drugs that can induce Fanconi syndrome and that patients on stavudine and lamivudine be monitored carefully for early signs of Fanconi syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580619     DOI: 10.1097/QAD.0b013e328303be50

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.

Authors:  Hui-Fang Hung; Hsiu-Hsi Chen
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

Review 2.  Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.

Authors:  Jia-Lin Jin; Piao Hu; Jia-Hong Lu; Su-Shan Luo; Xiao-Yun Huang; Xin-Hua Weng; Ji-Ming Zhang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 3.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 4.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 5.  Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Authors:  Carlos G Musso; Waldo H Belloso; Richard J Glassock
Journal:  World J Nephrol       Date:  2016-01-06

Review 6.  Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.

Authors:  Zygimantas C Alsauskas; Raj Kiran Medapalli; Michael J Ross
Journal:  Expert Opin Pharmacother       Date:  2011-01-21       Impact factor: 3.889

7.  Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).

Authors:  Ikwo Oboho; Alison G Abraham; Lorie Benning; Kathryn Anastos; Anjali Sharma; Mary Young; Pamela Burian; Monica Gandhi; Mardge Cohen; Lynda Szczech
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

8.  A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

Authors:  Steven J Reynolds; Cissy Kityo; Claire W Hallahan; Geoffrey Kabuye; Diana Atwiine; Frank Mbamanya; Francis Ssali; Robin Dewar; Marybeth Daucher; Richard T Davey; Peter Mugyenyi; Anthony S Fauci; Thomas C Quinn; Mark R Dybul
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 9.  Kidney disease in children and adolescents with perinatal HIV-1 infection.

Authors:  Rajendra Bhimma; Murli Udharam Purswani; Udai Kala
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

Review 10.  Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies.

Authors:  Syed K Haque; Gema Ariceta; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2012-12       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.